CHARLES TOWN, W.Va., Oct. 4 /PRNewswire-FirstCall/ -- Today ReBuilder Medical Technologies, Inc. announced that it has adjusted its sales projections for the quarter ending September 30, 2007 from a 10% increase over 3rd quarter 2006 to an 85% increase.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
"By expanding our marketing efforts, we have effectively increased our sales without increasing expensive Search Engine costs," says David B. Phillips, Ph.D. CEO of ReBuilder Medical Technologies, Inc. (http://www.rebuildermedical.com). We can now afford to reach beyond consumer marketing to the trusted advisor market of physicians and clinics. This shift in market emphasis can reduce our overall advertising costs, and increase sales because the physician can demo the ReBuilder System(R) and train the patient in his office setting. This may also have the effect of increasing the patient's confidence in the ReBuilder System(R). With our relationship with the physician firmly grounded with the ReBuilder System(R) we can then introduce him to our silver based diabetic personal hygiene products like SilverMouthWash(TM) and this should also increase sales."
According to the American Diabetes Association, there are over 20 million people in the US suffering with diabetes and 30% of these patients will eventually develop the pain, numbness and loss of mobility that accompany diabetic peripheral neuropathy. The overall total economic cost of diabetes is over $132 billion. One of every 10 dollars spent on health costs in America is spent on diabetes. With the graying of the baby boomers, these numbers will climb dramatically. Over the next three years, ReBuilder Medical Technologies, Inc. has targeted one percent of the diabetic market, or 43.5 million dollars.
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc. is a manufacturer of medical devices and innovative technologies founded by world-renowned medical device inventor David B. Phillips, Ph.D. The company's flagship product is its FDA registered ReBuilder System(R), used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery- powered medical product that provides a unique, non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical Technologies, Inc. also manufactures the Phillips Molluscum Treatment System(TM) for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum pathogen without side effects. The company is currently performing research and development on a number of other products as well.
ReBuilder Medical Technologies, Inc. is located in Charles Town, WV. CEO, Dr. David Phillips, Ph.D. is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System, which is used for the early detection of breast cancer, and the AcuPen, a hand-held device that provides the benefits of acupuncture without the use of needles.
More information on ReBuilder Medical Technologies, Inc. and its products can be found at: http://www.rebuildermedical.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward- looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
CONTACT: Daena Carter, ReBuilder Medical Technologies, Inc.
+1-304-725-2202
Web site: http://www.rebuildermedical.com//
